PT - JOURNAL ARTICLE AU - Keith Williams AU - Albert J. Pahk AU - Keiko Kashiwagi AU - Takashi Masuko AU - Nguyen D. Nguyen AU - Kazuei Igarashi TI - The Selectivity Filter of the<em>N</em>-Methyl-<span class="sc">d</span>-Aspartate Receptor: A Tryptophan Residue Controls Block and Permeation of Mg<sup>2+</sup> DP - 1998 May 01 TA - Molecular Pharmacology PG - 933--941 VI - 53 IP - 5 4099 - http://molpharm.aspetjournals.org/content/53/5/933.short 4100 - http://molpharm.aspetjournals.org/content/53/5/933.full SO - Mol Pharmacol1998 May 01; 53 AB - A hallmark feature of N-methyl-d-aspartate (NMDA) receptors is their voltage-dependent block by extracellular Mg2+. The structural basis for Mg2+ block is not fully understood. Although asparagine residues in the pore-forming M2 regions of NR1 and NR2 subunits influence Mg2+ block, it has been speculated that additional residues are likely to be involved. Here, we report the unexpected finding that a tryptophan residue in the M2 region of NR2 subunits controls Mg2+ block. An NR2B(W607L) mutation abolished block and greatly increased permeation of extracellular Mg2+. A similar effect was seen with a mutation at the equivalent residue in NR2A but not with mutations at the equivalent residue or adjacent residues in NR1. In NR2B, mutations that changed NR2B(W607) to asparagine (W607N) or alanine (W607A) also greatly reduced Mg2+ block, whereas mutations that changed W607 to the aromatic residues tyrosine (W607Y) or phenylalanine (W607F) had little or no effect on Mg2+ block. Furthermore, the W607L, W607N, and W607A mutants, but not the W607Y and W607F mutants, decreased Ba2+ permeability of NMDA channels. Thus, residue NR2B(W607) may be involved in binding of divalent cations, in particular Mg2+, through a cation-π interaction with the electron-rich aromatic ring of the tryptophan. We previously suggested that NR2B(W607) may contribute to the narrow constriction of the NMDA channel. A model is now proposed in which the M2 loop of NR2B is folded in such a way that NR2B(W607) is positioned at the narrow constriction, at a level similar to NR2B(N616) and NR1(N616), with these three residues forming a binding site for Mg2+. The American Society for Pharmacology and Experimental Therapeutics